These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25790192)

  • 1. Expression of Toll-like receptor -7 and -9 in B cell subsets from patients with primary Sjögren's syndrome.
    Karlsen M; Hansen T; Nordal HH; Brun JG; Jonsson R; Appel S
    PLoS One; 2015; 10(3):e0120383. PubMed ID: 25790192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR-7 and -9 Stimulation of Peripheral Blood B Cells Indicate Altered TLR Signalling in Primary Sjögren's Syndrome Patients by Increased Secretion of Cytokines.
    Karlsen M; Jonsson R; Brun JG; Appel S; Hansen T
    Scand J Immunol; 2015 Dec; 82(6):523-31. PubMed ID: 26332048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H1N1 vaccination in Sjögren's syndrome triggers polyclonal B cell activation and promotes autoantibody production.
    Brauner S; Folkersen L; Kvarnström M; Meisgen S; Petersen S; Franzén-Malmros M; Mofors J; Brokstad KA; Klareskog L; Jonsson R; Westerberg LS; Trollmo C; Malmström V; Ambrosi A; Kuchroo VK; Nordmark G; Wahren-Herlenius M
    Ann Rheum Dis; 2017 Oct; 76(10):1755-1763. PubMed ID: 28760805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Toll-like receptors 7, 8, and 9 in primary Sjögren's syndrome.
    Zheng L; Zhang Z; Yu C; Yang C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jun; 109(6):844-50. PubMed ID: 20399690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single Cell Based Phosphorylation Profiling Identifies Alterations in Toll-Like Receptor 7 and 9 Signaling in Patients With Primary Sjögren's Syndrome.
    Davies R; Sarkar I; Hammenfors D; Bergum B; Vogelsang P; Solberg SM; Gavasso S; Brun JG; Jonsson R; Appel S
    Front Immunol; 2019; 10():281. PubMed ID: 30846988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Toll-like receptor 7 signaling in labial salivary glands of primary Sjögren's syndrome patients.
    Shimizu T; Nakamura H; Takatani A; Umeda M; Horai Y; Kurushima S; Michitsuji T; Nakashima Y; Kawakami A
    Clin Exp Immunol; 2019 Apr; 196(1):39-51. PubMed ID: 30446998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered phenotype and Stat1 expression in Toll-like receptor 7/8 stimulated monocyte-derived dendritic cells from patients with primary Sjögren's syndrome.
    Vogelsang P; Karlsen M; Brun JG; Jonsson R; Appel S
    Arthritis Res Ther; 2014 Aug; 16(4):R166. PubMed ID: 25113744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of plasmacytoid dendritic cells by apoptotic particles - mechanism for the loss of immunological tolerance in Sjögren's syndrome.
    Ainola M; Porola P; Takakubo Y; Przybyla B; Kouri VP; Tolvanen TA; Hänninen A; Nordström DC
    Clin Exp Immunol; 2018 Mar; 191(3):301-310. PubMed ID: 29105068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Toll-Like Receptor 7 Signaling Pathway in Primary Sjögren's Syndrome-Associated Thrombocytopenia.
    Zhang S; Qu J; Wang L; Li M; Xu D; Zhao Y; Zhang F; Zeng X
    Front Immunol; 2021; 12():637659. PubMed ID: 33767707
    [No Abstract]   [Full Text] [Related]  

  • 10. Expansion of autoreactive unresponsive CD21-/low B cells in Sjögren's syndrome-associated lymphoproliferation.
    Saadoun D; Terrier B; Bannock J; Vazquez T; Massad C; Kang I; Joly F; Rosenzwajg M; Sene D; Benech P; Musset L; Klatzmann D; Meffre E; Cacoub P
    Arthritis Rheum; 2013 Apr; 65(4):1085-96. PubMed ID: 23279883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant IL-35 levels in patients with primary Sjogren's syndrome.
    Guo J; Gu M; Zhang W; Liu Y; Qian C; Deng A
    Scand J Immunol; 2018 Nov; 88(5):e12718. PubMed ID: 30589451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjögren's syndrome.
    Bohnhorst JØ; Bjørgan MB; Thoen JE; Natvig JB; Thompson KM
    J Immunol; 2001 Oct; 167(7):3610-8. PubMed ID: 11564773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Transcriptomic Profile of Monocytes from Patients With Sjögren's Syndrome Is Associated With Inflammatory Parameters and Is Mimicked by Circulating Mediators.
    Lopes AP; Bekker CPJ; Hillen MR; Blokland SLM; Hinrichs AC; Pandit A; Kruize AA; Radstake TRDJ; van Roon JAG
    Front Immunol; 2021; 12():701656. PubMed ID: 34413853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjögren's syndrome: the similarities and differences.
    Lin W; Jin L; Chen H; Wu Q; Fei Y; Zheng W; Wang Q; Li P; Li Y; Zhang W; Zhao Y; Zeng X; Zhang F
    Arthritis Res Ther; 2014 May; 16(3):R118. PubMed ID: 24887143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diminished CXCR5 expression in peripheral blood of patients with Sjögren's syndrome may relate to both genotype and salivary gland homing.
    Aqrawi LA; Ivanchenko M; Björk A; Ramírez Sepúlveda JI; Imgenberg-Kreuz J; Kvarnström M; Haselmayer P; Jensen JL; Nordmark G; Chemin K; Skarstein K; Wahren-Herlenius M
    Clin Exp Immunol; 2018 Jun; 192(3):259-270. PubMed ID: 29453859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overlap between differentially methylated DNA regions in blood B lymphocytes and genetic at-risk loci in primary Sjögren's syndrome.
    Miceli-Richard C; Wang-Renault SF; Boudaoud S; Busato F; Lallemand C; Bethune K; Belkhir R; Nocturne G; Mariette X; Tost J
    Ann Rheum Dis; 2016 May; 75(5):933-40. PubMed ID: 26183421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Toll-Like Receptors in Peripheral Blood Mononuclear Cells of Patients with Primary Sjögren's Syndrome.
    Karlsen M; Jakobsen K; Jonsson R; Hammenfors D; Hansen T; Appel S
    Scand J Immunol; 2017 Mar; 85(3):220-226. PubMed ID: 27943374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of immunoglobulin heavy chain rearrangements between peripheral and glandular B cells in a patient with primary Sjögren's syndrome.
    Hansen A; Jacobi A; Pruss A; Kaufmann O; Scholze J; Lipsky PE; Dörner T
    Scand J Immunol; 2003 May; 57(5):470-9. PubMed ID: 12753504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated EPSTI1 promote B cell hyperactivation through NF-κB signalling in patients with primary Sjögren's syndrome.
    Sun JL; Zhang HZ; Liu SY; Lian CF; Chen ZL; Shao TH; Zhang S; Zhao LL; He CM; Wang M; Zhang W; Chen H; Zhang FC
    Ann Rheum Dis; 2020 Apr; 79(4):518-524. PubMed ID: 32114510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome.
    Pontarini E; Fabris M; Quartuccio L; Cappeletti M; Calcaterra F; Roberto A; Curcio F; Mavilio D; Della Bella S; De Vita S
    Rheumatology (Oxford); 2015 Aug; 54(8):1429-34. PubMed ID: 25740829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.